Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression

Table 1 The correlation between clinicopathological parameters and lncNRA XIST expression levels in 106 gastric cancer patients

Variables	n	High XIST expression (%)	Low XIST expression (%)	P value
Age
< 60	74	35(64.8)	39(75.0)	0.253
≥ 60	32	19(35.2)	13(25.0)	0.253
Gender
Male	67	33(61.1)	34(65.3)	0.648
Female	39	21(38.9)	18(34.7)	0.648
Tumor size
< 5 cm	30	10(18.5)	20(38.4)	0.023^a
≥ 5 cm	76	44(81.5)	32(61.6)	0.023^a
Peritoneum dissemination
Absent	89	44(81.4)	45(86.5)	0.478
Present	17	10(18.6)	7(13.5)	0.478
Differentiation
Well	19	7(12.9)	12(23.0)	0.326
Moderate	36	18(33.3)	18(34.6)
Poor and others	51	29(43.8)	22(42.4)
Lymph node invasion
Absent	31	10(18.5)	21(40.3)	0.013^a
Present	75	44(81.5)	31(59.7)	0.013^a
Distant metastasis
Absent	78	34(62.9)	44(84.6)	0.011^a
Present	28	20(37.1)	8(15.4)	0.011^a
TNM stage
I-II	35	12(22.2)	23(44.2)	0.016^a
III-IV	71	42(77.8)	29(55.8)	0.016^a

ISSN: 1756-9966